Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Recently approved AmBisome label includes claim of superior safety compared to Abelcet

Feb. 16, 2000

New artemisinin derivatives from Hong Kong active against sensitive and resistant malarial strains

Feb. 15, 2000

Biovail acquires Canadian marketing rights for Ampligen

Feb. 15, 2000

Components of naturally occurring antimicrobial complex isolated at Schering-Plough

Feb. 14, 2000

Microbiotix and BioChem Pharma to develop novel antibiotic agents

Feb. 14, 2000

Bayer and marketing partners introduce new fluoroquinolone in Spain

Feb. 11, 2000

Improved topical formulations of aciclovir developed at Recordati

Feb. 11, 2000

Phase III trials to begin for BioCryst's influenza therapy

Feb. 10, 2000

Dainippon and Questcor modify antibacterial research agreement

Feb. 9, 2000

Antiinfluenza sialic acid derivatives emerge from R&D at RIKEN

Feb. 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...